IMbrave150 for HCC

Video

Data are reviewed from the phase 3 IMbrave150 trial for unresectable hepatocellular carcinoma.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
1 expert in this video
2 experts in this video
Related Content